← Evidence map

ArticleFrontiers in immunology2021

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.

Yihua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

58 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34721404